Latest Global Markets News

DroneShield Limited has reported a record-breaking second quarter with revenues surging 480% year-on-year, underpinned by a robust $176 million in committed sales and a $2.3 billion pipeline. The company is aggressively expanding manufacturing and investing in next-generation counter-drone technologies to meet soaring global demand.

Champion Iron Limited reported Q1 FY2026 results showing steady revenues and net income, alongside a major US$500 million bond issuance to refinance debt and a new partnership agreement for the Kami Project.

PolyNovo Limited reports a robust FY25 with nearly 29% sales growth, a significant cash increase to A$33.5 million, and expanding global market presence. The company’s strategic investments and product innovations signal strong momentum ahead.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Osteopore Limited reports a three-fold increase in craniofacial implant sales within a year of signing an exclusive distribution deal with Zimmer Biomet, signaling strong early traction across key global markets.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

Matrix Composites & Engineering has landed a significant A$35 million subsea buoyancy contract with a major international energy services firm, underpinning its growth trajectory into FY2026.

Noxopharm Limited has successfully completed the first low-dose cohort in its HERACLES clinical trial for SOF-SKN™, clearing the way for higher dose testing in autoimmune disease treatment.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

Tivan Limited has taken significant strides in financing its Speewah Fluorite Project, securing a conditional Letter of Support from Export Finance Australia and moving into the Northern Australia Infrastructure Facility’s due diligence phase. These developments mark important progress toward full project funding and highlight fluorite’s rising strategic importance.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Titomic Limited has successfully raised A$50 million through a strategic share placement, aiming to fuel its growth in industrial-scale metal additive manufacturing. The capital raise underscores investor confidence as the company prepares to expand its global footprint.